BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1673164)

  • 21. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
    Thoss VS; Piwko C; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies.
    Weber CJ; Marvin M; Krekun S; Koschitzky T; Karp F; Benson M; Feind CR
    Surgery; 1990 Dec; 108(6):1065-71. PubMed ID: 1978945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas.
    Reubi JC; Waser B; Khosla S; Kvols L; Goellner JR; Krenning E; Lamberts S
    J Clin Endocrinol Metab; 1992 May; 74(5):1082-9. PubMed ID: 1349024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of evidence for autocrine feedback regulation by somatostatin in somatostatin receptor-containing meningiomas.
    Reubi JC; Mengod G; Palacios JM; Horisberger U; Hackeng WH; Lamberts SW
    Cell Growth Differ; 1990 Jun; 1(6):299-303. PubMed ID: 1980601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of somatostatin and cortistatin receptors.
    Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
    Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
    Reubi JC; Schaer JC; Waser B; Mengod G
    Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin receptors in human colorectal cancer.
    Iftikhar SY; Thomas WM; Rooney PS; Morris DL
    Eur J Surg Oncol; 1992 Feb; 18(1):27-30. PubMed ID: 1346594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
    Saito H; Saito S
    Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin binding sites in human leptomeninx.
    Reubi JC; Maurer R; Lamberts SW
    Neurosci Lett; 1986 Oct; 70(2):183-6. PubMed ID: 2877422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum.
    Piwko C; Thoss VS; Probst A; Hoyer D
    Neuropharmacology; 1996 Jun; 35(6):713-23. PubMed ID: 8887980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors.
    Reubi JC; Häcki WH; Lamberts SW
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1127-34. PubMed ID: 2824549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative in vivo autoradiographic localization of [125I-Tyr11]somatostatin-14- and [Leu8,D-Trp22-125I-Tyr25]somatostatin-28-binding sites in rat brain.
    Patel YC; Baquiran G; Srikant CB; Posner BI
    Endocrinology; 1986 Nov; 119(5):2262-9. PubMed ID: 2876887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma.
    Mato E; Matías-Guiu X; Chico A; Webb SM; Cabezas R; Berná L; De Leiva A
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2417-20. PubMed ID: 9661621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
    Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
    Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular heterogeneity and biological activity of immunoreactive somatostatin in medullary carcinoma of the thyroid.
    Saito S; Saito H; Matsumura M; Ishimaru K; Sano T
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1117-22. PubMed ID: 6117566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
    Murthy KK; Srikant CB; Patel YC
    Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of somatostatin biosynthesis, somatostatin receptors and tumor growth in murine medullary thyroid carcinoma.
    Ouazzani L; Reubi JC; Volle GE; Lausson S; Pidoux E; Moukhtar MS; Treilhou-Lahille F
    Eur J Endocrinol; 1994 Nov; 131(5):522-30. PubMed ID: 7952164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solubilization and partial purification of somatostatin-28 preferring receptors from hamster pancreatic beta cells.
    Maletti M; Andersson M; Marie JC; Rosselin G; Mutt V
    J Biol Chem; 1992 Aug; 267(22):15620-5. PubMed ID: 1353498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of somatostatin receptors in the rat cerebellum during development.
    Gonzalez BJ; Leroux P; Bodenant C; Braquet P; Vaudry H
    J Neurochem; 1990 Sep; 55(3):729-37. PubMed ID: 1974603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative radioautographic study of somatostatin receptors heterogeneity in the rat extrahypothalamic brain.
    Krantic S; Martel JC; Weissmann D; Pujol JF; Quirion R
    Neuroscience; 1990; 39(1):127-37. PubMed ID: 1982463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.